A year with 988: What worked? What challenges lie ahead?

Public report cards for heart transplant centers are under fire for not being meaningful — potentially even misrepresentative of care quality — as a given

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes